Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Plos One
|
December 31, 2016
Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection
Brian M Maas, Owen Francis, Katie R Mollan, et al.
International Journal of Environmental Research and Public Health
|
January 20, 2021
Validation of a Self-Perceived Adaptive Behaviors Scale in Older Chilean Women and Percentiles for Evaluation
Rossana Gomez-Campos, Ruben Vidal-Espinoza, Luis Felipe Castelli Correia de Campos, et al.
The Journal of Infectious Diseases
|
July 21, 2020
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults
James E Moon, Christian Ockenhouse, Jason A Regules, et al.
Human Vaccines & Immunotherapeutics
|
July 16, 2019
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
Lorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, et al.
Science Translational Medicine
|
May 22, 2020
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against <i>Plasmodium falciparum</i> malaria
Isaie J Reuling, António M Mendes, Gerdie M de Jong, et al.
Plos Neglected Tropical Diseases
|
February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
Jason W Bennett, Anjali Yadava, Donna Tosh, et al.
Plos One
|
July 7, 2015
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
Christian F Ockenhouse, Jason Regules, Donna Tosh, et al.
NPJ Vaccines
|
February 6, 2025
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>
M Sanni Ali, Lisa Stockdale, Issaka Sagara, et al.
The Lancet. Infectious Diseases
|
August 25, 2023
Seasonal vaccination with RTS,S/AS01<sub>E</sub> vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial
Alassane Dicko, Jean-Bosco Ouedraogo, Issaka Zongo, et al.
NPJ Vaccines
|
October 17, 2018
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
Tommy Rampling, Katie J Ewer, Georgina Bowyer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Plos One
|
December 31, 2016
Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection
Brian M Maas, Owen Francis, Katie R Mollan, et al.
International Journal of Environmental Research and Public Health
|
January 20, 2021
Validation of a Self-Perceived Adaptive Behaviors Scale in Older Chilean Women and Percentiles for Evaluation
Rossana Gomez-Campos, Ruben Vidal-Espinoza, Luis Felipe Castelli Correia de Campos, et al.
The Journal of Infectious Diseases
|
July 21, 2020
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults
James E Moon, Christian Ockenhouse, Jason A Regules, et al.
Human Vaccines & Immunotherapeutics
|
July 16, 2019
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
Lorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, et al.
Science Translational Medicine
|
May 22, 2020
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against <i>Plasmodium falciparum</i> malaria
Isaie J Reuling, António M Mendes, Gerdie M de Jong, et al.
Plos Neglected Tropical Diseases
|
February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
Jason W Bennett, Anjali Yadava, Donna Tosh, et al.
Plos One
|
July 7, 2015
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
Christian F Ockenhouse, Jason Regules, Donna Tosh, et al.
NPJ Vaccines
|
February 6, 2025
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>
M Sanni Ali, Lisa Stockdale, Issaka Sagara, et al.
The Lancet. Infectious Diseases
|
August 25, 2023
Seasonal vaccination with RTS,S/AS01<sub>E</sub> vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial
Alassane Dicko, Jean-Bosco Ouedraogo, Issaka Zongo, et al.
NPJ Vaccines
|
October 17, 2018
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
Tommy Rampling, Katie J Ewer, Georgina Bowyer, et al.
Page
of 8